CSL could spend up to $2.2b on drug deal with Swiss biotech start-up
CSL could spend up to $2.2 billion developing a drug to combat rare kidney and liver disease under an exclusive…
Tag: 2.2B
Tiger Global launches $2.2B fund with AI bubble warning
The Buzz ■ Tiger Global launches Private Investment Partners 17 targeting $2.2B, down from $6B sought in previous fund according…
Home-equity startup Aven hits $2.2B valuation with $110M raise
Aven, a startup aimed at homeowners who want to tap their equity without the hassle of a traditional loan, has…